Antibody testing to predict SARS-CoV-2 risk in immunocompromised people

Lancet. 2025 Jan 25;405(10475):276-278. doi: 10.1016/S0140-6736(25)00098-4.

Author

Christopher J A Duncan¹

Affiliation

¹ Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK. Electronic address: christopher.duncan@ncl.ac.uk.

PMID: 39863352
DOI: 10.1016/S0140-6736(25)00098-4

No abstract available

Publication types

Comment